15 Who May Benefit Most From GLP-1s for Heart Health By addressing the root drivers of heart disease including inflammation, insulin resistance, and liver stress GLP-1s can be a powerful tool for anyone with significant cardiovascular risk, even if their weight is in the normal BMI range
RWD provides the depth and breadth needed to address critical questions, revealing how GLP-1s perform across medical histories, comorbidities, label expansions, and populations not studied in clinical trials (such as pregnant women)
But some say these medications didnt work for them due to side effects or lack of progress
However, most patients report seeing results two to three months after beginning treatment
Eur J Pharmacol (2021) 908:174310
GLP-1 agonists reduce insulin levels, and lower insulin triggers the kidneys to release stored sodium and water